Get started
Galectin Therapeutics Inc.
Long

Golden Cross event and heavy insider buying on GALT

30

  • Golden Cross formed
  • CEO takes 80% pay in stock
  • Billonaire chairman provided financing
  • Developing the leading drug candidate for advanced liver disease
LGALS3
goldenGrowthTechnical Indicators

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
goldenGrowthTechnical Indicators
LGALS3

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.